Healthcare Services

Global Iron Deficiency Anemia Market Revenue Expected To Reach $4.78 Billion By 2030

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Iron Deficiency Anemia Market Compare Between 2026 And 2030?

The market for iron deficiency anemia has experienced robust expansion in recent times. Projections indicate it will expand from $3.57 billion in 2025 to $3.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. Historically, this growth has been driven by factors such as the high prevalence of nutritional iron deficiency, the widespread use of oral iron supplements, chronic blood loss from gastrointestinal disorders, maternal anemia in developing regions, and limited access to advanced parenteral therapies.

The iron deficiency anemia market is poised for significant expansion in the coming years, with projections indicating it will reach $4.78 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is driven by a rising global burden of anemia, increased adoption of intravenous iron therapies, an expanding geriatric population, improved healthcare access in emerging markets, and enhanced diagnostic and screening initiatives. Key trends anticipated in this period include the growing embrace of parenteral iron therapies, an intensified focus on maternal and pediatric anemia management, the wider use of high-dose and long-acting iron formulations, the proliferation of home-based iron therapy and infusion services, and increasing awareness and screening programs for iron deficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21212&type=smp

What Are The Main Drivers Accelerating The Growth Of The Iron Deficiency Anemia Market?

The rising prevalence of nutritional deficiencies is projected to boost the iron deficiency anemia market in the future. Nutritional deficiency is defined as a state where the body lacks the required amounts of one or more vital nutrients like vitamins, minerals, proteins, or fats, essential for optimal health. The increase in nutritional deficiencies stems from poor dietary habits, including widespread consumption of processed foods, and food insecurity, which limits access to nutrient-dense foods for lower-income populations. Iron deficiency anemia, a common type of nutritional deficiency, occurs when inadequate dietary iron leads to a diminished red blood cell count, thus impairing the body’s oxygen transport capability. For instance, in February 2025, the World Health Organization, a Switzerland-based intergovernmental organization, reported that anaemia is estimated to affect 40% of children aged 6–59 months, 37% of pregnant women, and 30% of women between 15 and 49 years old. Therefore, the increasing instances of nutritional deficiencies are a key driver for the iron deficiency anemia market.

Which Segment Divisions Form The Structure Of The Iron Deficiency Anemia Market?

The iron deficiency anemia market covered in this report is segmented –

1) By Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion

2) By Distribution Channel: Hospital Pharmacy, Drug Stores and Retail Pharmacies, Online Pharmacies

3) By End Users: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Oral Iron Therapy: Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide-Iron Complex, Carbonyl Iron

2) By Parenteral Iron Therapy: Iron Sucrose, Ferric Carboxymaltose, Iron Dextran, Ferumoxytol, Ferric Gluconate

3) By Red Blood Cell Transfusion: Leukocyte-Reduced Red Blood Cell Transfusion, Washed Red Blood Cell Transfusion, Irradiated Red Blood Cell Transfusion

What Trends Are Affecting The Iron Deficiency Anemia Market Dynamics?

Leading companies in the iron deficiency anemia market are concentrating on creating novel solutions, such as intravenous iron injections, to provide a precise combination of nutrients that maximize absorption and enhance tolerance, thereby effectively addressing iron deficiency. This medical procedure involves introducing iron directly into the bloodstream to manage iron deficiency or anemia, especially when oral iron supplements prove inadequate or ineffective. An example is the launch of Redshot FCM in March 2024 by Cadila Pharmaceuticals, an India-based pharmaceutical company. This intravenous iron injection, containing ferric carboxymaltose, is designed for the effective treatment of iron deficiency anemia (IDA). This cutting-edge product is appropriate for adults and children older than one year who are unable to tolerate oral iron supplements. Characterized by a robust safety profile and a very low risk of anaphylaxis, Redshot FCM enables the delivery of significant iron doses in a single session, contributing to a swift improvement in hemoglobin levels. Its benefits are particularly notable for susceptible populations including pregnant women, the elderly, and cancer patients.

Which Industry Players Are Present In The Iron Deficiency Anemia Market?

Major companies operating in the iron deficiency anemia market are Sanofi S.A., Abbott Laboratories, Fresenius SE & Co. KGaA, Sandoz International GmbH, Perrigo Company, Cipla Limited, Dr. Reddy’s Laboratories Limited, Cadila Healthcare Limited, Zydus Cadila, Lupin Limited, Alkem Laboratories Limited, AMAG Pharmaceuticals Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, AdvaCare Pharma LLC

Access The Complete Iron Deficiency Anemia Market Report:

https://www.thebusinessresearchcompany.com/report/iron-deficiency-anemia-global-market-report

Which Regional Market Leads The Iron Deficiency Anemia Market?

North America was the largest region in the iron deficiency anemia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Iron Deficiency Anemia Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21212&type=smp

Browse Through More Reports Similar to the Global Iron Deficiency Anemia Market 2026, By The Business Research Company

Hemochromatosis Iron Overload Disease Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemochromatosis-iron-overload-disease-treatment-global-market-report

Anemia And Other Blood Disorder Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Chemotherapy Induced Anemia Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795